(Q79305372)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

[Treatment of acneiform rash by epidermal growth factor inhibitors with oral tetracyclines] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Montse Fernández-Guarino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Bibiana Pérez García

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Isabel Aldanondo Fernández de la Mora

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Cristina García-Millán

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Pilar Garrido López

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Pedro Jaén Olasolo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

Actas Dermo-Sifiliográficas

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

503-508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

Pharmacological background of EGFR targeting

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Comparison of Epidermal Growth Factor Binding and Receptor Distribution in Normal Human Epidermis and Epidermal Appendages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

[Epidermal growth factor receptor inhibitors side effects]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Tetracyclines: nonantibiotic properties and their clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

Acneiform eruption secondary to cetuximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-7310%2806%2973451-2

10.1016/S0001-7310(06)73451-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17067527%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference